BIRC5 and colorectal carcinoma: Similarly, Li et al. identified the prognostic value of miR-218 in CRC patients, reporting that high miR-218 expression promoted apoptosis and sensitized CRC cells to 5-FU treatments by suppressing TS and BIRC5 expression [56].